Prevalence of extended-spectrum beta-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 37, Issue 1, 2006, Pages 131-135

  Jitsurong, Siroj ^a   Yodsawat, Jareerat ^b  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b Hat Yai Hospital   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33744465004     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-51.
2. Chiew YF. Detection of extended-spectrum β-lactamases in a Singapore routine clinical microbiology laboratory. J Hosp 2004; 56: 328-9.
3. Cormican MG, Marshall SA, Jones RN. Detection of extended-spectrum β-lactamase (ESBL)-producing strains by the E test ESBL screen. J Clin Microbiol 1996; 34: 1880-4.
4. Coudron PE, Hanson ND, Climo MW. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. J Clin Microbiol 2003; 41: 772-7.
5. Essack SY. Laboratory detection of extended-spectrum β-lactamases (ESBLs) - the need for a reliable, reproducible method. Diag Microbiol Infect Dis 2000; 37: 293-5.
6. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended- spectrum β-lactamase-producing gram-negative bacteria in septicaemia neonates in a tertiary care hospital. J Med Microbiol 2003; 52: 421-5.
7. Kim BN, Woo JH, Kim MN, Ryu J, Kim YS. Clinical implications of extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 2002; 52: 99-106.
8. th ed. Washington DC: American Society of Microbiology, 1999: 438-571, 1526-43.
9. NCCLS (National Committee For Clinical Laboratory Standards). Performance standards for antimicrobial disk susceptibility testing. 7th ed. Approved standard M2-A7. Wayne, Pa: National Committee For Clinical Laboratory Standards, 2000.
10. Rhaman MM, Haq JA, Hossain MA, et al. Prevalence of extended-spectrum- producing Escherichia coli and Klebsiella pneumonias in an urban hospital in Dhaka, Bangladesh. Int J Antimicrob Agents 2004; 24: 508-10.
11. Schwaber MJ, Raney PM, Rasheed JK, et al. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp of enterobacteriaceae. J Clin Microbiol 2004; 42: 294-8.
12. Shah AA, Hasan F, Ahmed S, Hameed A. Extended-spectrum β-lactamases (ESBLs): characterization, epidemiology and detection. Crit Rev Microbiol 2004; 30: 25-32.
13. Sorlozano A, Gutierrez J, Palanca M, Soto MJ, Piedrola G. High incidence of extended-spectrum β-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method. Diag Microbiol Infect Dis 2004; 50: 131-4.
14. Sturenburg E, Mack D. Extended-spectrum β-lactamase: implications for the clinical microbiology laboratory, therapy and infection control. J Infect 2003; 47: 273-95.
15. Tenover FC, Raney PM, Williams PP, et al. Evaluation of the NCCLS extended-spectrum β-lactamase confirmation methods for Echerichia coli with isolates collected during project ICARE. J Clin Microbiol 2003; 41: 3142-6.
16. Wu TL, Siu LK, Su LH, et al. Outer membrane protein change combined with co-existing TEM-1 and SHV-1β-lactamases lead to false indentification of ESBL-producing Klebsiella pneumoniae. J Antimicrob Chemother 2001; 47: 755-61.
17. Xiong Z, Zhu D, Wang F, Zhang Y, Okamoto R, Inoue M. Investingation of extended-spectrum β-lactamase in Klebsiella pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis 2002; 44: 195-200.